With the prevalence of diabetes quadrupling in recent decades and currently impacting more than 500 million people in the world, it is no surprise that the technology for insulin delivery has also ...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced ...

Just a few weeks into the full-scale rollout of its Omnipod 5 insulin pump, Insulet has gotten the green light to expand the device’s reach even further. When the FDA originally cleared the automated, ...

The dream of a completely closed-loop system for diabetes management is now closer than ever for many Type 1 diabetes patients, thanks to the widespread U.S. launch of a completely automated, ...

Mass.-based insulin-pump maker Insulet acquired assets related to Bigfoot Biomedical's pump-based automated insulin delivery (AID) technologies for $25 million. Insulet and Bigfoot offer two distinct ...

“As part of our ongoing efforts to bring Omnipod technology to more people living with diabetes around the world, we’re excited to announce that Omnipod DASH will soon be available in Australia,” said ...

New insulin pod is expected to launch at the end of August for type 1 diabetes. These pods are expected to cost $800 for two months worth of supply. A new device is set to launch early this coming ...

Insulin pumps are the most advanced insulin delivery technology available today for people with type 1 and type 2 diabetes. An insulin pump replaces injections with a syringe or insulin pen, using an ...

According to Precedence Research, the global tubeless insulin pump market size will grow from USD 2.92 billion in 2025 to nearly USD 13.65 billion by 2034, with an expected CAGR of 18.74% from 2025 to ...

The diabetes community raised a cheer for model Lila Moss when she confidently strode down a high-fashion runway with her insulin pump on full display. At the end of September, Moss, the 19-year-old ...